A detailed history of Broderick Brian C transactions in Merck & Co., Inc. stock. As of the latest transaction made, Broderick Brian C holds 22,202 shares of MRK stock, worth $2.44 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
22,202
Previous 21,569 2.93%
Holding current value
$2.44 Million
Previous $2.85 Million 3.44%
% of portfolio
0.61%
Previous 0.66%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$123.8 - $132.96 $78,365 - $84,163
633 Added 2.93%
22,202 $2.75 Million
Q1 2024

May 03, 2024

BUY
$113.24 - $131.95 $1.58 Million - $1.84 Million
13,944 Added 182.87%
21,569 $2.85 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $150,270 - $163,530
1,500 Added 24.49%
7,625 $831,000
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $2,715 - $2,959
-25 Reduced 0.41%
6,125 $706,000
Q4 2022

Feb 09, 2023

BUY
$87.44 - $112.11 $43,720 - $56,055
500 Added 8.85%
6,150 $682,000
Q1 2022

May 17, 2022

BUY
$73.51 - $82.4 $2,572 - $2,884
35 Added 0.62%
5,650 $463,000
Q4 2021

Feb 08, 2022

SELL
$72.28 - $90.54 $250,667 - $313,992
-3,468 Reduced 38.18%
5,615 $431,000
Q3 2021

Nov 10, 2021

SELL
$71.68 - $78.83 $19,138 - $21,047
-267 Reduced 2.86%
9,083 $683,000
Q2 2021

Aug 09, 2021

SELL
$70.31 - $77.77 $7,031 - $7,777
-100 Reduced 1.06%
9,350 $727,000
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $75,746 - $89,221
-1,100 Reduced 10.43%
9,450 $729,000
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $5,023 - $5,575
-70 Reduced 0.66%
10,550 $862,000
Q3 2020

Oct 28, 2020

SELL
$73.18 - $82.95 $165,020 - $187,052
-2,255 Reduced 17.51%
10,620 $880,000
Q2 2020

Jul 28, 2020

SELL
$70.42 - $80.13 $31,689 - $36,058
-450 Reduced 3.38%
12,875 $996,000
Q1 2020

May 07, 2020

SELL
$63.36 - $87.82 $11,088 - $15,368
-175 Reduced 1.3%
13,325 $1.03 Million
Q4 2019

Jan 15, 2020

BUY
$77.58 - $87.54 $79,209 - $89,378
1,021 Added 8.18%
13,500 $1.23 Million
Q3 2019

Nov 04, 2019

SELL
$76.08 - $82.93 $91,448 - $99,681
-1,202 Reduced 8.79%
12,479 $1.05 Million
Q2 2019

Jul 24, 2019

SELL
$69.84 - $81.59 $176,695 - $206,422
-2,530 Reduced 15.61%
13,681 $1.15 Million
Q1 2019

Apr 29, 2019

SELL
$69.58 - $79.36 $158,990 - $181,337
-2,285 Reduced 12.35%
16,211 $1.35 Million
Q4 2018

Jan 24, 2019

SELL
$65.24 - $75.71 $65,239 - $75,710
-1,000 Reduced 5.13%
18,496 $1.41 Million
Q3 2018

Oct 15, 2018

SELL
$57.69 - $67.84 $63,459 - $74,624
-1,100 Reduced 5.34%
19,496 $1.38 Million
Q2 2018

Jul 30, 2018

SELL
$50.83 - $59.72 $5,083 - $5,972
-100 Reduced 0.48%
20,596 $1.25 Million
Q1 2018

Apr 24, 2018

SELL
$50.96 - $59.23 $20,791 - $24,165
-408 Reduced 1.93%
20,696 $1.13 Million
Q4 2017

Feb 02, 2018

SELL
$51.62 - $61.64 $766,040 - $914,737
-14,840 Reduced 41.29%
21,104 $1.19 Million
Q3 2017

Oct 26, 2017

BUY
$58.67 - $63.13 $2.11 Million - $2.27 Million
35,944
35,944 $2.3 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $278B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Broderick Brian C Portfolio

Follow Broderick Brian C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

News

Stay updated on Broderick Brian C with notifications on news.